NCT03489291View on ClinicalTrials.gov

Dose Confirmation Trial of AAV5-hFIXco-Padua

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

October 30, 2018

Study Completion Date

September 21, 2023

Conditions
Hemophilia B
Interventions
GENETIC

AAV5-hFIXco-Padua (AMT-061)

Single intravenous infusion of AAV5-hFIXco-Padua (AMT-061)

Trial Locations (4)

48109

University of Michigan, Ann Arbor

85016

Phoenix Childrens Hospital, Phoenix

92122

University of California, San Diego, San Diego

95817

University of California, Davis, Sacramento

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY